CVRx
Manufacturing · Minnesota, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9201 W Broadway Ave Ste 650, Minneapolis...Phone Number
(763) 416-2840Website
www.cvrx.comRevenue
$59.1 MillionStock Symbol
CVRXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Explore more
CVRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CVRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CVRx recently announced quarterly report
Check if CVRx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CVRx has new funding data
Congratulate Masked Content for being promoted to Masked Content at CVRx
CVRx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CVRx had a recent Job posting/layoffs
Product Launch: Get notified when CVRx launches new products
Check out if CVRx is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to CVRx
Compare insights from companies similar to CVRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CVRx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CVRx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CVRx.
CVRx financials insights
Gather financial insights about CVRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series C
$30.1M
2007
Series D
$65M
2008
Series A
$84M
2013
Private Equity
$29.6M
Series F
$12M
2014
Debt
$15M
2016
Multiple Rounds
$170.7M
2020
Other Financing Round
$50M
CVRx Tech Stack
A closer look at the technologies used by CVRx
Most Recent Scoops
Person-Based
Medical Research
Person-Based
Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Earnings, Forecasting, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
CVRx News & Media
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami on Wednesday, June 10, 2026. The Company's presentation will begin at 8:00 a.m. (ET).CVRx to Present at the William Blair 46th Annual Growth Stock Conference
MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the William Blair 46th Annual Growth Stock Conference in Chicago on Tuesday, June 2, 2026. The Company's presentation will begin at 10:40 a.m. (CT).CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Humana has issued a Medicare Advantage coverage policy for Barostim therapy, effective May 1, 2026. Humana, a national health insurance company with the second largest Medicare Advantage program in the U.S., provides cCVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript
CVRx, Inc. (CVRX) Q1 2026 Earnings Call May 11, 2026 4:30 PM EDTCompany ParticipantsKevin Hykes - President, CEO & DirectorJared Oasheim - Chief...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CVRx
Sign Up For FreeTo access detailed company insights
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart fai... Read More
